Showing results (1381-1390 of 1,423) with videos related to

Sort By:
Pageof 143
Epilepsy & Behavior : E&B|December 21, 2020
Tolerability of lacosamide rapid dose titration: A randomized, multicenter, prospective, open-label studyYong-Won Shin, Jangsup Moon, Yong Won Cho, et al.
Sleep Medicine|January 23, 2021
Altered insular functional connectivity in isolated REM sleep behavior disorder: a data-driven functional MRI studyJung-Ick Byun, Kwang Su Cha, Minah Kim, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 25, 2016
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort StudyWoo-Jin Lee, Soon-Tae Lee, Jangsup Moon, et al.
Epilepsia|August 19, 2015
The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean populationJangsup Moon, Han-Ki Park, Kon Chu, et al.
Cancer Research and Treatment|August 19, 2009
Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancerEui Bae Kim, Yong Park, Seh Jong Park, et al.
Annals of Neurology|December 28, 2016
Anti-LGI1 encephalitis is associated with unique HLA subtypesTae-Joon Kim, Soon-Tae Lee, Jangsup Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?Myung-Ju Ahn, Byeong-Bae Park, Jin Seok Ahn, et al.
Journal of Neurosurgery|June 17, 2023
Responsive neurostimulation as a treatment for super-refractory focal status epilepticus: a systematic review and case seriesLia D Ernst, Ahmed M Raslan, Angela Wabulya, et al.
Cancer Research and Treatment|March 14, 2018
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung CancerDong-Wan Kim, Hoon-Gu Kim, Joo-Hang Kim, et al.
Plos One|December 31, 2013
Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinomaHye Sook Kim, Jae Sook Sung, Song-Ju Yang, et al.
Pageof 143